BRPI0911961A2 - agente terapêutico para dor - Google Patents

agente terapêutico para dor

Info

Publication number
BRPI0911961A2
BRPI0911961A2 BRPI0911961A BRPI0911961A BRPI0911961A2 BR PI0911961 A2 BRPI0911961 A2 BR PI0911961A2 BR PI0911961 A BRPI0911961 A BR PI0911961A BR PI0911961 A BRPI0911961 A BR PI0911961A BR PI0911961 A2 BRPI0911961 A2 BR PI0911961A2
Authority
BR
Brazil
Prior art keywords
pain
therapeutic agent
therapeutic
agent
Prior art date
Application number
BRPI0911961A
Other languages
English (en)
Inventor
Hiroki Hamano
Koji Yoshinaga
Takayuki Horii
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of BRPI0911961A2 publication Critical patent/BRPI0911961A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0911961A 2008-05-15 2009-05-14 agente terapêutico para dor BRPI0911961A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008128735 2008-05-15
PCT/JP2009/002109 WO2009139168A1 (ja) 2008-05-15 2009-05-14 疼痛治療薬

Publications (1)

Publication Number Publication Date
BRPI0911961A2 true BRPI0911961A2 (pt) 2015-10-13

Family

ID=41318543

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911961A BRPI0911961A2 (pt) 2008-05-15 2009-05-14 agente terapêutico para dor

Country Status (18)

Country Link
US (2) US20110059956A1 (pt)
EP (1) EP2305654B1 (pt)
JP (1) JP5533649B2 (pt)
KR (1) KR101614966B1 (pt)
CN (1) CN102026987B (pt)
AU (1) AU2009247440B2 (pt)
BR (1) BRPI0911961A2 (pt)
CA (1) CA2723623C (pt)
DK (1) DK2305654T3 (pt)
ES (1) ES2550790T3 (pt)
HU (1) HUE026358T2 (pt)
MX (1) MX2010012425A (pt)
PT (1) PT2305654E (pt)
RU (1) RU2486900C2 (pt)
SG (2) SG189814A1 (pt)
TW (1) TWI459948B (pt)
WO (1) WO2009139168A1 (pt)
ZA (1) ZA201007839B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103374000B (zh) * 2012-04-13 2015-11-11 中国科学院广州生物医药与健康研究院 嘧啶并二氮杂卓类化合物及其药用组合物和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484917A (en) * 1993-06-16 1996-01-16 Pfizer Inc. Substituted tetrahydrobenzazepinones
JP3999819B2 (ja) * 1996-12-10 2007-10-31 ゼリア新薬工業株式会社 １，５―ベンゾジアセピン誘導体
EP1234818B1 (en) * 1999-12-02 2004-09-08 Zeria Pharmaceutical Co., Ltd. Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same
PL1839662T3 (pl) * 2005-01-19 2010-08-31 Zeria Pharm Co Ltd Środek przeciwnowotworowy

Also Published As

Publication number Publication date
JPWO2009139168A1 (ja) 2011-09-15
WO2009139168A1 (ja) 2009-11-19
EP2305654A4 (en) 2012-03-21
CN102026987A (zh) 2011-04-20
ES2550790T3 (es) 2015-11-12
JP5533649B2 (ja) 2014-06-25
AU2009247440A1 (en) 2009-11-19
EP2305654B1 (en) 2015-10-14
SG10201502377RA (en) 2015-05-28
KR101614966B1 (ko) 2016-04-22
DK2305654T3 (en) 2016-01-11
PT2305654E (pt) 2016-02-04
MX2010012425A (es) 2010-12-17
CA2723623C (en) 2016-01-19
CA2723623A1 (en) 2009-11-19
RU2486900C2 (ru) 2013-07-10
SG189814A1 (en) 2013-05-31
AU2009247440B2 (en) 2013-09-26
US20150038495A1 (en) 2015-02-05
EP2305654A1 (en) 2011-04-06
HUE026358T2 (en) 2016-06-28
ZA201007839B (en) 2012-02-29
TW200946122A (en) 2009-11-16
US20110059956A1 (en) 2011-03-10
CN102026987B (zh) 2014-03-12
KR20110021763A (ko) 2011-03-04
TWI459948B (zh) 2014-11-11
RU2010151433A (ru) 2012-06-20

Similar Documents

Publication Publication Date Title
BR112013011874A2 (pt) compostos e métodos para tratar dor
BRPI0821145A2 (pt) Agente terapêutico para prurido
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
EP2119444A4 (en) THERAPEUTIC AGENT FOR PAIN
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI0810081A2 (pt) Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
BRPI0916931A2 (pt) agentes terapêuticos
PT2582366E (pt) Combinação terapêutica para o tratamento da dor
PT3058875T (pt) Sistema para tratamento cosmético e imagiologia
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI0821660A2 (pt) Combinações de agentes terapêuticos para tratamento de câncer
BR112012001819A2 (pt) métodos para tratamento de dor
BRPI1007636A2 (pt) Composição farmacêutica, forma de dosagem, método para a preparação da composição farmacêutica, método de preparação da forma de dosagem e método de tratamento da dor
BR112013014583A2 (pt) composição farmacêutica, e, métodos para o tratamento de inflamação, para o tratamento da dor, e para preparar 3-metanossulfonilpropionitrila
BRPI0920030A2 (pt) agente de oclusão do tecido
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
DK2144905T3 (da) Terapeutiske midler
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0812209A2 (pt) Partícula de liberação contendo agente de benefício
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
BRPI1014528A2 (pt) compostos para tratamento de inflamação e dor
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
EP3381471C0 (en) PAIN TREATMENT
BRPI0924107A2 (pt) inibidores de hsp90 para tratamento terapêutico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]